The Norwood Scale: Classifying Male Pattern Baldness

The Norwood Scale is the most widely used clinical framework for staging male pattern baldness, providing a standardized visual map of hair loss progression. This page explains how the scale is structured, what each stage indicates, and how clinicians use stage assignments to evaluate candidacy for intervention. Understanding the classification system is foundational to any informed discussion about hair restoration options and treatment planning.

Definition and Scope

Male pattern baldness — formally termed androgenetic alopecia — affects approximately 50% of men by age 50, according to the American Academy of Dermatology (AAD). The Norwood Scale, originally published by James Hamilton in 1951 and revised by O'Tar Norwood in 1975, provides the taxonomy that hair restoration professionals, dermatologists, and clinical researchers use to communicate the extent of hair loss in a reproducible way.

The scale covers the full spectrum of male hair loss, from minimal recession at the temples to complete loss of hair on the crown and top of the scalp, leaving only a horseshoe-shaped band of hair around the sides and back. This residual donor zone is the anatomical basis for surgical planning in follicular unit extraction and related procedures. The regulatory context for hair restoration — including FDA oversight of devices and drugs used in treatment — often references patient staging to define appropriate use conditions.

How It Works

The Norwood Scale divides male pattern baldness into 7 primary stages, with a Type A variant that modifies stages II through V. The classification is based on two observable parameters: the position and depth of the frontal hairline recession, and the presence and size of vertex (crown) thinning.

The 7 Primary Stages:

  1. Stage I — No significant recession. The hairline is intact across the forehead.
  2. Stage II — Slight recession at the temples, forming a triangular or irregular pattern. Hair loss is minimal and symmetrical.
  3. Stage III — Deepening temporal recession that is visible enough to qualify as baldness under clinical standards. Vertex thinning may or may not be present (Stage III Vertex is a recognized sub-classification).
  4. Stage IV — More severe frontal and temporal recession combined with a distinct bald area at the crown. A band of hair separates the two areas.
  5. Stage V — The strip separating the front and crown bald areas narrows significantly. Both zones continue to expand.
  6. Stage VI — The connecting band disappears, merging the frontal and crown bald areas into a single large zone.
  7. Stage VII — The most advanced stage. Hair is confined to a narrow horseshoe-shaped band at the sides and back of the scalp. This donor region is typically the only hair that retains resistance to dihydrotestosterone (DHT).

Type A Variant: The Type A pattern differs from the standard progression in one critical way: hair loss advances uniformly from front to back without developing an isolated crown bald spot. In Type A variants, the frontal hairline recedes continuously rearward, and a bridge of hair between the front and vertex never forms. This pattern is observed at stages II through V and affects surgical planning because the vertex may retain more density than expected for a given frontal stage.

Common Scenarios

Stage II–III: Patients presenting at these stages are often in their 20s or early 30s. Clinicians typically prioritize medical management — finasteride or minoxidil — before recommending surgery, because active progression at this stage can undermine graft placement results. The International Society of Hair Restoration Surgery (ISHRS) notes that stabilizing loss before surgery is a standard planning consideration.

Stage IV–V: This range represents the most common window for surgical candidacy. Donor hair supply is still substantial, the pattern of loss is established enough to plan a natural-looking hairline, and the contrast between donor and recipient zones is clearly defined. Graft counts in this range commonly span 2,000 to 3,500 follicular units, depending on the individual's donor density.

Stage VI–VII: At these advanced stages, the available donor supply becomes the binding constraint. Scalp donor hair may be insufficient to achieve full coverage, and clinicians may evaluate body hair as a supplemental source, or recommend scalp micropigmentation as an alternative or adjunct.

Decision Boundaries

The Norwood stage is one of 4 primary variables that factor into transplant candidacy assessment, alongside donor density, hair caliber, and the stability of ongoing loss.

Stage-based eligibility boundaries observed in clinical practice:

The Type A versus standard pattern distinction also affects design decisions. Type A patients tend to require front-loaded graft allocation rather than the crown-first approach that may suit some standard Stage V patients.

Clinicians use the Norwood stage in conjunction with trichoscopy, density measurements in grafts-per-cm², and miniaturization analysis to build a complete picture. No single stage assignment determines treatment outcome — it is a classification input, not a prescription. The AAD and ISHRS both publish clinical guidance that frames staging as a descriptive tool within a broader evaluation protocol.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)